Monitoring Clinical Trials of Drugs by Industry Sponsors Quiz Latest Update Graded A
All unused investigational agents are expected to be returned to the sponsor at the: ✔✔Termination site visit.
Which of the following should take place during periodic site visits? ✔✔Identification of protocol violations
Which of the following best describes when the majority of case report form (CRF) data are verified against source record information? ✔✔Periodic site visits
When should the sponsor-monitor conduct the most detailed review of the study protocol with the site's study staff? ✔✔Site initiation visit
The FDA requires retention of investigational drug study records for: ✔✔At least two years after the investigational drug's approval by the FDA.
- / 1